Hologic

Discover Hologic, a leading American company in the medical field, offering a diverse range of diagnostic equipment and mastectomy devices. 

Since its acquisition of Cytyc in 2007, specializing in cervical cancer and preterm births, for $6.2 billion, Hologic has emerged as a major player in the sector. In 2012, the acquisition of Gen-Probe for $3.75 billion strengthened its expertise in blood diagnostics and sexually transmitted diseases. 

Then, in 2017, the acquisition of Cynosure, for $1.65 billion, expanded its offerings to non-surgical aesthetic procedures. 

 With a history rich in strategic acquisitions, Hologic is committed to providing innovative solutions to address the most complex health needs.